Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
PPAR Ligands Function as Suppressors That Target Biological Actions of HMGB1
View through CrossRef
High mobility group box 1 (HMGB1), which has become one of the most intriguing molecules in inflammatory disorders and cancers and with which ligand-activated peroxisome proliferator-activated receptors (PPARs) are highly associated, is considered as a therapeutic target. Of particular interest is the fact that certain PPAR ligands have demonstrated their potent anti-inflammatory activities and potential anticancer effects. In this review article we summarize recent experimental evidence that PPAR ligands function as suppressors that target biological actions of HMGB1, including intracellular expression, receptor signaling cascades, and extracellular secretion of HMGB1 in cell lines and/or animal models. We also propose the possible mechanisms underlying PPAR involvement in inflammatory disorders and discuss the future therapeutic value of PPAR ligands targeting HMGB1 molecule for cancer prevention and treatment.
Title: PPAR Ligands Function as Suppressors That Target Biological Actions of HMGB1
Description:
High mobility group box 1 (HMGB1), which has become one of the most intriguing molecules in inflammatory disorders and cancers and with which ligand-activated peroxisome proliferator-activated receptors (PPARs) are highly associated, is considered as a therapeutic target.
Of particular interest is the fact that certain PPAR ligands have demonstrated their potent anti-inflammatory activities and potential anticancer effects.
In this review article we summarize recent experimental evidence that PPAR ligands function as suppressors that target biological actions of HMGB1, including intracellular expression, receptor signaling cascades, and extracellular secretion of HMGB1 in cell lines and/or animal models.
We also propose the possible mechanisms underlying PPAR involvement in inflammatory disorders and discuss the future therapeutic value of PPAR ligands targeting HMGB1 molecule for cancer prevention and treatment.
Related Results
ROLE OF HMGB1 IN DOXORUBICIN-INDUCED MYOCARDIAL APOPTOSIS AND ITS REGULATION PATHWAY
ROLE OF HMGB1 IN DOXORUBICIN-INDUCED MYOCARDIAL APOPTOSIS AND ITS REGULATION PATHWAY
Objectives
Doxorubicin (DOX) is a widely used anti-tumour agent. The clinical application of the medication is limited by its side effect which can elicit myocard...
Abstract 2600: HMGB1, a potential new target for mesothelioma therapy
Abstract 2600: HMGB1, a potential new target for mesothelioma therapy
Abstract
Malignant mesothelioma (MM) is a very aggressive cancer that causes 2000-3000 deaths annually in the U.S. and is resistant to current therapies. Diagnosis f...
HMGB1 mediates lipopolysaccharide-induced macrophage autophagy and pyroptosis
HMGB1 mediates lipopolysaccharide-induced macrophage autophagy and pyroptosis
Abstract
Autophagy and pyroptosis of macrophages play important protective or detrimental roles in sepsis. However, the underlying mechanisms remain unclear. High mobility ...
Role of HMGB1 in Cisplatin-Persistent Lung Adenocarcinoma Cell Lines
Role of HMGB1 in Cisplatin-Persistent Lung Adenocarcinoma Cell Lines
Significant advances have been made recently in the development of targeted therapy for lung adenocarcinoma. However, platinum-based chemotherapy remains as the cornerstone in the ...
Is anti-HMGB1 Antibody a Potential Characteristic Autoantibody for Sjögren's Syndrome?
Is anti-HMGB1 Antibody a Potential Characteristic Autoantibody for Sjögren's Syndrome?
Abstract
BACKGROUND: Sjögren's syndrome (SS) is a common chronic inflammatory autoimmune disease, affects about 0.33% to 0.77% population in China. The positive for antinuc...
Obésité : inflammation du tissu adipeux HMGB1, une nouvelle adipokine ?
Obésité : inflammation du tissu adipeux HMGB1, une nouvelle adipokine ?
L’obésité est aujourd’hui considérée comme une pandémie majeure et 2,8 millions d’adultes meurent chaque année de maladies associées à cette pathologie. Plus que l’augmentation de ...
HMGB1 as a cytokine and therapeutic target
HMGB1 as a cytokine and therapeutic target
HMGB1 is an abundant nuclear and cytoplasmic protein present in mammalian cells. It is traditionally known as a DNA binding protein involved in maintenance of nucleosome structure ...
Neuroprotective and anti-inflammatory effects of Yingqiao San on epileptogenesis are mediated by inhibiting HMGB1 translocation and regulating the HMGB1/TLR4 signaling pathway
Neuroprotective and anti-inflammatory effects of Yingqiao San on epileptogenesis are mediated by inhibiting HMGB1 translocation and regulating the HMGB1/TLR4 signaling pathway
Abstract
Background: Epileptogenesis was the latency period of epilepsy. Neuronal damage and subsequent inflammatory response were the basic mechanisms of epileptogenesis. ...